World Courier opened new offices worldwide in 2018, and unveiled personalized supply chain teams to support direct-to-patient, cell and gene therapy, and clinical trial execution.
The company began investing in technology solutions and infrastructure in 2015 and has since implemented upgrades in Canada, Portugal, and Japan. Improvements following the most recent investment are set to reach additional markets in 2019.
Sam Herbert, president of World Courier told us, “As technology continues to drive innovation in pharmaceutical care, we must also use it to progress the leading edge of logistics and commercialization platforms. We recognized the opportunity to evolve our solutions even further and provide customers, particularly those introducing highly specialized therapies, greater value.”
This technology “transformation” includes real-time temperature and GPS tracking, and will support system integration and enhance order entry functionality for customers.
“In addition, we will now have the ability to further integrate and enable reliable coordination between customers, airlines, and regulatory agencies, all of whom need to be in lock-step as products make their way from manufacturers to patients,” said Herbert.
“As the pharmaceutical and biomedical industries evolve, our partners expect World Courier to continue to lead the industry in specialty logistics best practices,” he said, adding that the company is focusing on proving logistics and efficiency throughout the supply chain by expanding its ability to support partners in additional markets.
Investment details have not been disclosed at this time.